Dan Frampton
Impact in
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- HIV/AIDS drug development and treatment
- Virology top 5%
- HIV Research and Treatment
Papers in
- Virology 8
- HIV Research and Treatment 7
-
- SARS-CoV-2 and COVID-19 Research 7
- HIV/AIDS drug development and treatment 4
- SARS-CoV-2 detection and testing 3
- COVID-19 Clinical Research Studies 2
- Co-authors
- Paul Kellam (8 shared papers)Eleni Nastouli (6 shared papers)Zisis Kozlakidis (5 shared papers)Judith Breuer (4 shared papers)Ruth Bridget Ferns (4 shared papers)Andrew C Hayward (5 shared papers)Deenan Pillay (3 shared papers)Paul R. Grant (3 shared papers)
- Journals
- The Journal of Infectious Diseases (3 papers)Journal of Antimicrobial Chemotherapy (3 papers)Scientific Reports (3 papers)PLoS Pathogens (2 papers)PLoS ONE (2 papers)
- Partner nations
- United KingdomUnited StatesSouth Africa
In The Last Decade
Dan Frampton
30 papers receiving 1.4k citations
Dan Frampton's Hit Papers
Peers
Comparison fields: 5 of 99
- Infectious Diseases 845
- Virology 128
- Modeling and Simulation 120
- Animal Science and Zoology 83
- Immunology 154
Countries citing papers authored by Dan Frampton
This map shows the geographic impact of Dan Frampton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Frampton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Frampton more than expected).
Fields of papers citing papers by Dan Frampton
This network shows the impact of papers produced by Dan Frampton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Frampton. The network helps show where Dan Frampton may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Frampton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway Hit paper breakdown → | 2022 | 457 |
| 2 | Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study Hit paper breakdown → | 2021 | 290 |
| 3 | 2021 | 67 | |
| 4 | 2014 | 63 | |
| 5 | 2020 | 58 | |
| 6 | 2018 | 50 | |
| 7 | 2018 | 44 | |
| 8 | 2022 | 41 | |
| 9 | 2017 | 35 | |
| 10 | 2014 | 35 | |
| 11 | 2017 | 33 | |
| 12 | 2016 | 25 | |
| 13 | 2018 | 21 | |
| 14 | 2023 | 19 | |
| 15 | 2020 | 18 | |
| 16 | 2018 | 18 | |
| 17 | 2019 | 17 | |
| 18 | 2019 | 16 | |
| 19 | 2014 | 16 | |
| 20 | 2015 | 14 |
About Dan Frampton
Dan Frampton is a scholar working on Virology, Infectious Diseases, Immunology, Epidemiology and Modeling and Simulation, having authored 30 papers that have together received 1.4k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (7 papers), HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (4 papers), Influenza Virus Research Studies (3 papers), SARS-CoV-2 detection and testing (3 papers), COVID-19 Clinical Research Studies (2 papers), Genomics and Phylogenetic Studies (2 papers) and Respiratory viral infections research (2 papers). The work is most often cited by research in Infectious Diseases (845 citations), Virology (128 citations), Modeling and Simulation (120 citations), Animal Science and Zoology (83 citations) and Immunology (154 citations). Dan Frampton has collaborated with scholars based in United Kingdom, United States and South Africa. Frequent co-authors include Paul Kellam, Eleni Nastouli, Zisis Kozlakidis, Judith Breuer, Ruth Bridget Ferns, Andrew C Hayward, Deenan Pillay, Paul R. Grant, Meleri Jones and Rachael J. M. Bashford-Rogers. Their work appears in journals such as The Journal of Infectious Diseases, Journal of Antimicrobial Chemotherapy, Scientific Reports, PLoS Pathogens and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.